Senseibio
1 known investors
Faeth Therapeutics is a biotech developing PIKTOR, an all-oral combination therapy that inhibits multiple nodes of the PAM (PI3K/AKT/mTOR) oncogenic pathway. It focuses on cancer treatments, with programs in endometrial cancer and HR+/HER2- breast cancer.
Investors · 1
Competitors · 7
by search overlap
Robinhood14 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha10 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwits10 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TradingView9 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Itiger9 shared keywordsTiger Brokers is a global online brokerage that lets clients trade equities, futures, options, and funds across U.S., Hong Kong, Singapore, and Australian markets through its Tiger Trade mobile app. Beyond brokerage, it offers ESOP management, investment banking, wealth management, and investor education, and is listed on NASDAQ under the ticker TIGR.
Faeth Therapeutics9 shared keywordsFaeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway. Its lead candidate, PIKTOR, is an all-oral combination targeting PI3K-alpha, mTORC1, and mTORC2 for cancers including endometrial and HR+/HER2- breast cancer.
TipRanks9 shared keywordsFinancial analysis and stock research platform.
Companies competing with Senseibio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Senseibio do?
- Faeth Therapeutics is a biotech developing PIKTOR, an all-oral combination therapy that inhibits multiple nodes of the PAM (PI3K/AKT/mTOR) oncogenic pathway. It focuses on cancer treatments, with programs in endometrial cancer and HR+/HER2- breast cancer.
- Who are Senseibio's investors?
- Senseibio's investors include Future Ventures.